Searched for
BIO SAFETY LEVEL
Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
13,000 volunteers administered 2nd dose of Covaxin in phase-3 trials: Bharat BiotechCovaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...
Bharat Biotech inks pact with Precisa Medicamentos for Covaxin supplies to BrazilThe Brazilian Ambassador to India Andr Aranha Corra do Lago expressed keen interest on behalf of his government towards procuring the vacci...
Bharat Biotech set to dispatch first consignment of Covaxin"Today in the evening the first consignment is going out of Hyderabad.... (it is from ) Bharat Biotech. It is going to 11 destinations," an...
A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of CovaxinThe approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...
Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of CovaxinThe company statement has come after an expert panel of India's central drug authority recommended granting permission for restricted use o...
Bharat Biotech's top brass calls on vice presidentThe indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment faci...
Bharat Biotech seeks marketing nod again for its vaccine“The drug regulator is examining the application,” an official told ET, adding that the regulator is yet to fix the date for the subject ex...
News of Chinese lab creating 'anthrax-like pathogens' in Pakistan 'fake': Foreign OfficeThe Wuhan Institute of Virology has drawn the international spotlight in recent months because the novel coronavirus is thought to have ori...
Serum Institute of India to apply for local trials on Oxford's vaccine by AugustSII, the largest vaccine manufacturer in the world, has tied up with AstraZeneca to manufacture the Covid-19 vaccine. SII’s vaccine candida...
War against Covid-19: Meil firm iCOMM Tele teams up with DRDO to develop mobile virology labThe mobile lab is built as per the bio-safety standards of the World Health Organisation and the Indian Council of Medical Research, said a...
Rs one lakh crore for railway safety fund: Arun JaitleyHe also said that Railways will get Rs 1,31,000 crore for capex and development expenditure in 2017-18.
Open-field trials of GM corn in Pune draws controversyMonsanto’s GM maize is being tested at two agricultural universities in Maharashtra — MPKV and the Vasantrao Naik Marathwada Krishi Vidyape...
How to fix US bio-security leaks? Close some labs"One of the things that we want to do is reduce the number of laboratories that work with dangerous agents to the absolute minimum necessar...
Rail budget 2012: Railways propose SPV to eliminate all unmanned level crossingsIndian Railways today proposed to set up a special purpose vehicle (SPV) to eliminate all level crossings in the country in the next five y...
- Asia gets its first Bio Safety Level-4 facility
Biovet has launched Asia's first Bio Safety Level-4 (BSL-4) manufacturing facility, specifically designed to enable product development and...